• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像上神经母细胞瘤图像定义风险因素的综述。

A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.

作者信息

Chen Alan M, Trout Andrew T, Towbin Alexander J

机构信息

Department of Radiology, Cincinnati Children's Hospital, 3333 Burnet Ave., MLC 5031, Cincinnati, OH, 45229, USA.

出版信息

Pediatr Radiol. 2018 Aug;48(9):1337-1347. doi: 10.1007/s00247-018-4117-9. Epub 2018 Aug 4.

DOI:10.1007/s00247-018-4117-9
PMID:30078048
Abstract

Neuroblastoma is the most common extracranial solid malignancy in children. Historically, neuroblastoma has been staged using the International Neuroblastoma Staging System (INSS), which relies on surgical staging. This is problematic because surgical resection can vary among surgeons and tumors and occurs at interval times from diagnosis. In 2009 the International Neuroblastoma Risk Group (INRG) created a new staging system that relies on preoperative imaging for staging. The INRG staging system consists of 20 image-defined risk factors (IDRF) across multiple organ systems, which help predict surgical outcomes/adequacy of resection and can be combined with clinical data to provide up-front risk stratification. The purpose of this review is to describe both the INSS and INRG staging systems and their limitations and to illustrate the definitions and IDRFs that comprise the INRG staging system.

摘要

神经母细胞瘤是儿童最常见的颅外实体恶性肿瘤。从历史上看,神经母细胞瘤一直使用国际神经母细胞瘤分期系统(INSS)进行分期,该系统依赖手术分期。这存在问题,因为不同外科医生对肿瘤的手术切除情况可能不同,而且手术切除在诊断后的不同时间进行。2009年,国际神经母细胞瘤风险组(INRG)创建了一种新的分期系统,该系统依赖术前影像学进行分期。INRG分期系统由多个器官系统中的20个图像定义风险因素(IDRF)组成,这些因素有助于预测手术结果/切除的充分性,并可与临床数据相结合以提供术前风险分层。本综述的目的是描述INSS和INRG分期系统及其局限性,并说明构成INRG分期系统的定义和IDRF。

相似文献

1
A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.磁共振成像上神经母细胞瘤图像定义风险因素的综述。
Pediatr Radiol. 2018 Aug;48(9):1337-1347. doi: 10.1007/s00247-018-4117-9. Epub 2018 Aug 4.
2
Neuroblastoma image-defined risk factors in adrenal neuroblastoma: role of radiologist.肾上腺神经母细胞瘤的神经母细胞瘤图像定义风险因素:放射科医生的作用
Gland Surg. 2019 Sep;8(Suppl 3):S168-S177. doi: 10.21037/gs.2019.06.01.
3
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.国际神经母细胞瘤风险组(INRG)分期系统:一份INRG特别工作组报告。
J Clin Oncol. 2009 Jan 10;27(2):298-303. doi: 10.1200/JCO.2008.16.6876. Epub 2008 Dec 1.
4
Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.图像定义的风险因素与神经母细胞瘤患者的手术根治性和局部复发相关。
Klin Padiatr. 2016 Apr;228(3):118-23. doi: 10.1055/s-0041-111175. Epub 2016 Feb 29.
5
How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis.影像界定风险因素(IDRFs)对神经母细胞瘤患者手术结果和生存率的预测效果如何?一项系统评价和荟萃分析。
Pediatr Surg Int. 2020 Aug;36(8):897-907. doi: 10.1007/s00383-020-04696-y. Epub 2020 Jun 12.
6
Bilateral adrenal neuroblastoma in the infant: Is it an image-defined risk factor?婴儿双侧肾上腺神经母细胞瘤:它是一种影像定义的风险因素吗?
Pediatr Hematol Oncol. 2016 May;33(4):259-63. doi: 10.3109/08880018.2016.1160169.
7
Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.新辅助化疗后神经源性肿瘤的图像定义风险因素评估有助于预测术中风险因素和切除的完整性。
Pediatr Blood Cancer. 2015 Sep;62(9):1543-9. doi: 10.1002/pbc.25511. Epub 2015 Mar 27.
8
Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.局部性神经母细胞瘤中影像定义风险因素的有效性:来自日本西部两个中心的报告
J Pediatr Surg. 2015 Dec;50(12):2102-6. doi: 10.1016/j.jpedsurg.2015.08.039. Epub 2015 Aug 28.
9
A non-inferiority study of MRI versus CT for staging and image-defined risk factor assessment in the preoperative work-up of abdominopelvic neuroblastoma.MRI 与 CT 在前腹部神经母细胞瘤术前分期和影像定义危险因素评估中的非劣效性研究。
Eur J Radiol. 2024 Aug;177:111580. doi: 10.1016/j.ejrad.2024.111580. Epub 2024 Jun 17.
10
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.不可切除神经母细胞瘤的影像定义风险因素:国际小儿肿瘤学会(SIOPEN)关于发病率、化疗引起的变化及对手术结果影响的研究
Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26605. Epub 2017 Apr 25.

引用本文的文献

1
Atypical Pelvic Tumors in Children.儿童非典型盆腔肿瘤
Cancers (Basel). 2025 Feb 12;17(4):619. doi: 10.3390/cancers17040619.
2
Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma.神经母细胞瘤高危组与非高危组解剖学影像特征的分层
Cancer Control. 2025 Jan-Dec;32:10732748251315883. doi: 10.1177/10732748251315883.
3
Intra- and interobserver agreement in evaluation of image-defined risk factors on computed tomography in pediatric neuroblastoma.小儿神经母细胞瘤计算机断层扫描图像定义风险因素评估中的观察者内和观察者间一致性

本文引用的文献

1
Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.扩散加权磁共振成像对小儿神经母细胞瘤肿瘤特征、鉴别及监测的诊断价值
Rofo. 2017 Jul;189(7):640-650. doi: 10.1055/s-0043-108993. Epub 2017 May 16.
2
Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.扩散加权成像在鉴别不同组织学类型和分化程度的胸腹部神经母细胞瘤中的作用
J Med Imaging Radiat Oncol. 2017 Dec;61(6):718-724. doi: 10.1111/1754-9485.12615. Epub 2017 May 16.
3
Pediatr Radiol. 2025 Feb;55(2):305-311. doi: 10.1007/s00247-024-06138-6. Epub 2025 Jan 2.
4
Quantitative MRI in Childhood Neuroblastoma: Beyond the Assessment of Image-defined Risk Factors.儿童神经母细胞瘤的定量 MRI:超越图像定义危险因素的评估。
Radiol Imaging Cancer. 2024 Nov;6(6):e240089. doi: 10.1148/rycan.240089.
5
Risk factors, impact and treatment of postoperative lymphatic leakage in children with abdominal neuroblastoma operated on by laparotomy.剖腹手术治疗儿童腹部神经母细胞瘤术后淋巴漏的危险因素、影响及治疗。
BMC Surg. 2024 May 29;24(1):168. doi: 10.1186/s12893-024-02459-3.
6
Image-defined risk factors associated with MYCN oncogene amplification in neuroblastoma and their association with overall survival.与神经母细胞瘤中MYCN癌基因扩增相关的图像定义风险因素及其与总生存期的关联。
Abdom Radiol (NY). 2024 Jun;49(6):1949-1960. doi: 10.1007/s00261-024-04196-w. Epub 2024 Mar 4.
7
A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients.一种与p53依赖性NTRK1激活及神经母细胞瘤患者生存率提高相关的潜在预后基因特征。
Cancers (Basel). 2024 Feb 8;16(4):722. doi: 10.3390/cancers16040722.
8
Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival.神经母细胞瘤肿瘤切除前后的局部磁共振成像:残留疾病对无事件生存期的影响
J Clin Med. 2023 Nov 24;12(23):7297. doi: 10.3390/jcm12237297.
9
A narrative review of radiomics and deep learning advances in neuroblastoma: updates and challenges.神经母细胞瘤放射组学和深度学习进展的叙述性综述:更新与挑战。
Pediatr Radiol. 2023 Dec;53(13):2742-2755. doi: 10.1007/s00247-023-05792-6. Epub 2023 Nov 10.
10
Diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in pediatric neuroblastoma.CT 和 MRI 联合血清 LDH、NSE、CEA 和 MYCN 检测对小儿神经母细胞瘤的诊断价值。
World J Surg Oncol. 2023 Aug 18;21(1):251. doi: 10.1186/s12957-023-03131-5.
Clinical manifestations of neuroblastoma with head and neck involvement in children.
儿童头颈部受累神经母细胞瘤的临床表现
Int J Pediatr Otorhinolaryngol. 2017 Jun;97:157-162. doi: 10.1016/j.ijporl.2017.04.013. Epub 2017 Apr 10.
4
Diffusion weighted imaging in differentiating malignant and benign neuroblastic tumors.扩散加权成像在鉴别恶性和良性神经母细胞瘤中的应用
Jpn J Radiol. 2016 Sep;34(9):620-4. doi: 10.1007/s11604-016-0565-z. Epub 2016 Jul 14.
5
PET/CT in the Evaluation of Neuroblastoma.PET/CT在神经母细胞瘤评估中的应用
PET Clin. 2008 Oct;3(4):551-61. doi: 10.1016/j.cpet.2009.03.006. Epub 2009 Jul 25.
6
MIBG in Neuroblastoma Diagnostic Imaging and Therapy.间碘苄胍在神经母细胞瘤诊断成像与治疗中的应用
Radiographics. 2016 Jan-Feb;36(1):258-78. doi: 10.1148/rg.2016150099.
7
124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.124I-间碘苄胍:一种用于评估神经母细胞瘤的有前景的新型正电子发射放射性药物。
Nucl Med Rev Cent East Eur. 2015;18(2):102-6. doi: 10.5603/NMR.2015.0024.
8
Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.伴有MYCN扩增结节的4S期复合型神经母细胞瘤的治疗
J Pediatr Hematol Oncol. 2014 Jan;36(1):e31-5. doi: 10.1097/MPH.0b013e3182847376.
9
Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review.小儿神经母细胞瘤原发和转移瘤:MRI 表现:影像学综述。
Magn Reson Imaging. 2012 Sep;30(7):893-906. doi: 10.1016/j.mri.2012.02.028. Epub 2012 Apr 12.
10
Pediatrics: diagnosis of neuroblastoma.儿科学:神经母细胞瘤的诊断。
Semin Nucl Med. 2011 Sep;41(5):345-53. doi: 10.1053/j.semnuclmed.2011.05.001.